ATE267263T1 - Eukaryotische genexpressionskassette und deren verwendungen - Google Patents

Eukaryotische genexpressionskassette und deren verwendungen

Info

Publication number
ATE267263T1
ATE267263T1 AT98900570T AT98900570T ATE267263T1 AT E267263 T1 ATE267263 T1 AT E267263T1 AT 98900570 T AT98900570 T AT 98900570T AT 98900570 T AT98900570 T AT 98900570T AT E267263 T1 ATE267263 T1 AT E267263T1
Authority
AT
Austria
Prior art keywords
expression cassette
gene expression
eukaryotic gene
herpes simplex
simplex virus
Prior art date
Application number
AT98900570T
Other languages
English (en)
Inventor
Robert Coffin
David Latchman
Original Assignee
Biovex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovex Ltd filed Critical Biovex Ltd
Application granted granted Critical
Publication of ATE267263T1 publication Critical patent/ATE267263T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98900570T 1997-01-10 1998-01-12 Eukaryotische genexpressionskassette und deren verwendungen ATE267263T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700411.3A GB9700411D0 (en) 1997-01-10 1997-01-10 Eukaryotic gene expression cassette and uses thereof
PCT/GB1998/000074 WO1998030707A2 (en) 1997-01-10 1998-01-12 Eukaryotic gene expression cassette and uses thereof

Publications (1)

Publication Number Publication Date
ATE267263T1 true ATE267263T1 (de) 2004-06-15

Family

ID=10805768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900570T ATE267263T1 (de) 1997-01-10 1998-01-12 Eukaryotische genexpressionskassette und deren verwendungen

Country Status (15)

Country Link
EP (2) EP1441033A3 (de)
JP (1) JP2001508294A (de)
KR (1) KR100507399B1 (de)
CN (1) CN1231589C (de)
AT (1) ATE267263T1 (de)
AU (1) AU749064B2 (de)
BR (1) BR9806866A (de)
CA (1) CA2278326A1 (de)
DE (1) DE69824027T2 (de)
DK (1) DK1021553T3 (de)
ES (1) ES2221980T3 (de)
GB (1) GB9700411D0 (de)
IL (2) IL130876A0 (de)
PT (1) PT1021553E (de)
WO (1) WO1998030707A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801930D0 (en) 1998-01-29 1998-03-25 Univ London Mutant herpes simplex viruses and uses thereof
GB9807865D0 (en) * 1998-04-09 1998-06-10 Univ London Herpes simplex virus latency associated transcript polypeptides
US6713067B2 (en) 1998-07-31 2004-03-30 Biovex Limited Herpes viruses for immune modulation
AU760308B2 (en) * 1998-07-31 2003-05-15 Cambridge University Technical Services Limited Latency-active regulatory sequences of herpesviruses and latency-inactive herpesviruses for gene transfer
GB9930418D0 (en) * 1999-12-22 2000-02-16 Neurovex Ltd Replication incompetent herpes virus vectors
US7063851B2 (en) 2000-04-12 2006-06-20 Biovex Limited Herpes viruses for immune modulation
CA2422748C (en) 2000-09-21 2011-08-09 Dsm N.V. Talaromyces xylanases
AUPR518501A0 (en) 2001-05-22 2001-06-14 Unisearch Limited Yin yang-1
TWI328612B (en) 2002-07-25 2010-08-11 Dsm Ip Assets Bv Genes and their encoded polypeptides involved in the biosynthetic pathway of vitamin b12, vectors and host cells comprising the genes, and process for producing vitamin b12
AU2003269220A1 (en) * 2002-09-27 2004-04-19 Powderject Research Limited Nucleic acid constructs for gene expression
GB0317511D0 (en) 2003-07-25 2003-08-27 Biovex Ltd Viral vectors
WO2005080581A2 (en) * 2004-02-17 2005-09-01 University Of Florida Research Foundation, Inc. Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression
WO2011130749A2 (en) 2010-04-16 2011-10-20 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-hsv receptors
JP6726824B2 (ja) * 2013-07-17 2020-07-22 ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション 効率的な遺伝子送達用途のための非毒性ｈｓｖベクター及びその製造のための補完細胞
DK3184641T3 (da) 2013-10-28 2020-08-03 Univ Of Pittsburgh - Of The Commonwealth System Of Higher Education Onkolytisk hsv-vektor
EP3400291B2 (de) 2016-01-08 2024-02-28 Replimune Limited Manipulierter virus
AU2017212713B2 (en) 2016-01-27 2023-01-19 Oncorus, Inc. Oncolytic viral vectors and uses thereof
GB201700350D0 (en) * 2017-01-09 2017-02-22 Replimune Ltd Altered virus
MX2020000993A (es) 2017-07-26 2020-07-22 Oncorus Inc Vectores virales oncolíticos y usos de estos.
CN112601547A (zh) 2018-06-21 2021-04-02 雷普利穆内有限公司 使用溶瘤病毒的治疗
EP3976806A1 (de) * 2019-05-30 2022-04-06 Solidus Biosciences, Inc. Rekombinanter herpesvirusvektor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849571A (en) * 1990-10-10 1998-12-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Latency active herpes virus promoters and their use
CA2092645A1 (en) * 1992-03-13 1993-09-14 Maureen K. Highkin Production of recombinant proteins using herpes virus promoters and vp16 transactivators

Also Published As

Publication number Publication date
JP2001508294A (ja) 2001-06-26
CA2278326A1 (en) 1998-07-16
KR100507399B1 (ko) 2005-08-10
EP1441033A2 (de) 2004-07-28
EP1441033A3 (de) 2004-12-01
WO1998030707A3 (en) 1998-09-11
EP1021553B1 (de) 2004-05-19
ES2221980T3 (es) 2005-01-16
EP1021553A2 (de) 2000-07-26
PT1021553E (pt) 2004-09-30
BR9806866A (pt) 2000-04-18
KR20000070037A (ko) 2000-11-25
GB9700411D0 (en) 1997-02-26
IL130876A (en) 2006-08-20
DK1021553T3 (da) 2004-09-27
WO1998030707A2 (en) 1998-07-16
AU749064B2 (en) 2002-06-20
CN1250480A (zh) 2000-04-12
CN1231589C (zh) 2005-12-14
IL130876A0 (en) 2001-01-28
AU5566998A (en) 1998-08-03
DE69824027T2 (de) 2004-10-28
DE69824027D1 (de) 2004-06-24

Similar Documents

Publication Publication Date Title
DE69824027D1 (de) Eukaryotische genexpressionskassette und deren verwendungen
NO303831B1 (no) Isolert DNA-sekvens, vektor, vertscelle, polypeptid og anvendelse in vitro av polypeptidet ved en fremgangsmÕte for transfeksjon av hematopoeseceller med eksogen DNA
ATE79649T1 (de) Herpes simplex-virus als vektor.
MX9800719A (es) Proteinas de transporte y sus usos.
ES2150894T1 (es) Vector de baculovirus modificado por proteinas de envoltura para terapia genica.
ATE321869T1 (de) Fusionproteine für intra- und interzelluläre transport und deren verwendungen
DE69634752D1 (de) Adenovirale vektoren beinhaltend ein prostata spezifisches antigen (psa) "response element"
AU3675095A (en) Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
ES2164260T3 (es) Vectores virales para la terapia genica.
WO1998027204A3 (en) AAV split-packaging genes and cell lines comprising such genes for use in the production of recombinant AAV vectors
ZA957797B (en) Use of a non-mammalian DNA virus to express an exogenous gene in a mammalian cell
IE842210L (en) Vaccine
AU1851895A (en) Host-vector system for use in gene therapy
DE3853474D1 (de) Vektor zur integrationsstellenunabhängigen genexpression in säugetier-wirtszellen.
ES2196014T3 (es) Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes.
AU1278695A (en) Homologous recombination antibody expression system for murine cells
BR9711998A (pt) Herpesvìrus saimiri como vetor viral.
NO963627L (no) Gener og genetiske elementer assosiert med kontroll av neoplastisk transformasjon i pattedyrceller
WO2002014527A3 (en) Gp64-null baculoviruses pseudotyped with heterologous envelope proteins
AU582288B2 (en) Vector and method for achieving high level expression in eukaryotic cells
AU1814995A (en) Galanin receptor, nucleic acids, transformed cells and uses thereof
AU692395B2 (en) Recombinant herpesvirus with the use of gB gene promoter
AU7151687A (en) Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
AU2233297A (en) Promoter
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1021553

Country of ref document: EP

REN Ceased due to non-payment of the annual fee